These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30940233)

  • 1. Does obesity and diabetes mellitus metastasize to the brain? "Metaboptosis" and implications for drug discovery and development.
    McIntyre RS; Rong C; Mansur RB; Brietzke E
    CNS Spectr; 2019 Oct; 24(5):467-469. PubMed ID: 30940233
    [No Abstract]   [Full Text] [Related]  

  • 2. Advancement of Technology for Drug Discovery and Development - Part II.
    Niu B
    Curr Top Med Chem; 2020; 20(1):3. PubMed ID: 31994458
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptor variants and the development of centrally acting medications
.
    Neale SA; Kambara K; Salt TE; Bertrand D
    Dialogues Clin Neurosci; 2019; 21(2):149-157. PubMed ID: 31636489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novo sets sights on obesity market with diabetes drug.
    Sheridan C
    Nat Biotechnol; 2014 Nov; 32(11):1071-2. PubMed ID: 25380424
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicinal chemistry of glucagon-like peptide receptor agonists.
    Jones LH; Price DA
    Prog Med Chem; 2013; 52():45-96. PubMed ID: 23384666
    [No Abstract]   [Full Text] [Related]  

  • 6. [The biguanides].
    Policlinico Prat; 1967 Oct; 74(40):1368-71. PubMed ID: 5605525
    [No Abstract]   [Full Text] [Related]  

  • 7. The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship.
    Nauck MA
    Metabolism; 2020 Feb; 103():154031. PubMed ID: 31785258
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural compound renews hope for diabetes and obesity therapeutic target.
    Merk D; Schubert-Zsilavecz M
    Future Med Chem; 2015; 7(7):833-5. PubMed ID: 26061101
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of the adipose senile diabetic using Silubin retard].
    Enders W
    Munch Med Wochenschr; 1966 May; 108(19):1063-8. PubMed ID: 6014764
    [No Abstract]   [Full Text] [Related]  

  • 10. Implications of sex-related differences in central nervous system disorders for drug research and development.
    Butlen-Ducuing F; Balkowiec-Iskra E; Dalla C; Slattery DA; Ferretti MT; Kokras N; Balabanov P; De Vries C; Mellino S; Santuccione Chadha A
    Nat Rev Drug Discov; 2021 Dec; 20(12):881-882. PubMed ID: 34226696
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Relationship Between Cancers and Diseases with Insulin Resistance.
    He J
    Curr Pharm Des; 2017; 23(25):3627-3628. PubMed ID: 29022507
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality use of medicines for people with diabetes.
    Lehmann J
    Collegian; 1997 Apr; 4(2):33-5. PubMed ID: 9265512
    [No Abstract]   [Full Text] [Related]  

  • 13. APD-356 (Arena).
    Jandacek RJ
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1051-6. PubMed ID: 16259227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy for the patient with obesity.
    Bray GA; Ryan DH
    Circulation; 2012 Apr; 125(13):1695-703. PubMed ID: 22474312
    [No Abstract]   [Full Text] [Related]  

  • 15. Experiences with Adebit in the treatment of the maturity onset diabetes.
    Bretán M; Balázsi I
    Ther Hung; 1970; 18(2):72-6. PubMed ID: 5478796
    [No Abstract]   [Full Text] [Related]  

  • 16. Focusing on the Link between Diabetes, Alzheimer's Disease and Cancer for the Discovery of New Medicines.
    Yang X; Wang K
    Curr Top Med Chem; 2016; 16(7):675-6. PubMed ID: 26381416
    [No Abstract]   [Full Text] [Related]  

  • 17. [Single and group education of children and adolescents with diabetes mellitus in the hospital].
    Maiwald S
    Kinderkrankenschwester; 1998 Apr; 17(4):150-1. PubMed ID: 9616572
    [No Abstract]   [Full Text] [Related]  

  • 18. What regulatory science can bring for CNS drug development.
    Gispen-de Wied C; Stoyanova-Beninska V
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):967-8. PubMed ID: 26024929
    [No Abstract]   [Full Text] [Related]  

  • 19. Research profile. Choosing and losing. Why do some people skip their med? John D. Piette, Ph.D.
    Curry A
    Diabetes Forecast; 2008 Mar; 61(3):63-4, 66. PubMed ID: 18446980
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoglycaemia as a barrier to improved glycaemic control.
    Davidson JA
    Int J Clin Pract Suppl; 2000 Sep; (112):57-62. PubMed ID: 11064953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.